Evidence map›Paper›PMID 33652275›Full record

ReviewChemosphere2021

Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline.

Muneeb Ullah, Abdul Wahab, Sumbul Saeed, Shahid Ullah Khan, Haider Ali, Shah Humayun, Banzeer Ahsan Abbasi, Shah Saud, Khalid Naveed, Sher Aslam Khan and 1 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Chemosphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Muneeb UllahDepartment of Pharmacy, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.
Abdul WahabDepartment of Pharmacy, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan. Electronic address: wahabscholar@yahoo.com.
Sumbul SaeedCollege of Plant Sciences and Technology, Huazhong Agricultural University, Wuhan, 430070, China. Electronic address: sumbulsaeed@webmail.hzau.edu.cn.
Shahid Ullah KhanCollege of Plant Sciences and Technology, Huazhong Agricultural University, Wuhan, 430070, China.
Haider AliDepartment of Pharmacy, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.
Shah HumayunPakistan Institute of Medical Sciences (pims), Pakistan.
Banzeer Ahsan AbbasiDepartment of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University Islamabad, Pakistan.
Shah SaudDepartment of Horticulture, Northeast Agricultural University, Harbin, China.
Khalid NaveedDepartment of Agronomy, University of Haripur, Khyber Pakhtunkhwa, Pakistan.
Sher Aslam KhanDepartment of Plant Breeding & Genetics, University of Haripur, Khyber Pakhtunkhwa, Pakistan.
Shah FahadDepartment of Agronomy, University of Haripur, Khyber Pakhtunkhwa, Pakistan. Electronic address: shah_fahad80@yahoo.com.
Kohat University of Science and Technology · PKUniversity of Haripur · PKHuazhong Agricultural University · CNNortheast Agricultural University · CNPakistan Institute of Medical Sciences · PKQuaid-i-Azam University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel coronavirus (2019-nCoV) is an acute life-threatening disease, emerged in China, which imposed a potentially immense toll in terms of public health emergency due to high infection rate and has a devastating economic impact that attracts the world's attention. After that, on January 30, 2020, it was officially declared as a global pandemic by World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) recognized it as a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and the disease named Coronavirus Disease-19 (COVID-19). Several studies have been ameliorated the active role of COVID-19 transmission, etiology, pathogenicity, and mortality rate as serious impact on human life. The symptoms of this disease may include fever, fatigue, cough and some peoples are severely prone to gastrointestinal infection. The elderly and seriously affected peoples are likely concerned with serious outcomes. In this review, we mainly aimed to provide a benchmark summary of the silent characteristics and findings of some candidates for antiviral drugs and immunotherapies such as plasma therapy, cytokine therapy, antibodies, intravenous immunoglobulin, and pharmaceutical health concerns that are related to this disease.

Indexed as

COVID-19Pharmaceutical PreparationsAgedChinaHumansPandemicsSARS-CoV-2Pharmaceutical PreparationsClinical characteristicsCOVID-19DiagnosisOriginPharmaceutical servicesSARS-CoV-2Transmission

Identifiers

PMID33652275
PMCPMC7884917
OpenAlexW3130394729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.